CME Group is bringing single-stock futures back to US screens on July 27. The contracts are simpler than options and cheaper on upfront margin than buying stock outright - but they carry real risk, and you need to know exactly what you are trading before you touch them.
Single-stock futures are back in the US market. CME Group said on June 30 that it plans to launch the contracts on July 27, pending completion of regulatory review, with 55 standard contracts and 22 micro contracts across more than 50 leading US stocks. Nvidia, SpaceX, Apple, Amazon, Alphabet, Meta, Tesla and Micron are all in the first batch.
That is the hook. A product that disappeared when OneChicago shut down in September 2020 is returning through the largest futures exchange in the country, aimed at the same stocks investors already argue about every day. If you trade Nvidia options, hedge Apple exposure, or follow SpaceX after its 2026 listing, CME is trying to put a futures contract in front of you before the summer is over.
The basic design is plain enough. According to CME's contract specifications, standard single-stock futures use a 100-share multiplier, while micro contracts use a 10-share multiplier. They are financially settled, not physically delivered, and final settlement is tied to the official closing price of the underlying stock on its primary listing exchange on expiration day. Trading is scheduled from 5 p.m. CT to 4 p.m. CT Sunday through Friday, with a one-hour daily maintenance break.
That access matters. Equity options stop when the stock market closes. Futures keep trading while earnings reactions, overseas market moves and macro shocks are still moving prices. You don't need to love leverage to see why that will appeal to active traders.
The simple part is the selling point
The honest case for single-stock futures over options is that they remove a lot of machinery. Options carry Greeks. Delta moves as the share price moves. Theta eats at the position every day you hold it. Implied volatility can punish you even when you are directionally right. Futures give you a cleaner bet on the future price of the stock.
Clean does not mean gentle. This is still leverage.
CME says the contracts will be margined through SPAN, with minimum initial and maintenance margin for outright long or short positions set at 15% of notional value under CFTC and SEC rules. CME's own capital-efficiency note compares that with a fully funded stock purchase at 100% upfront capital and a Reg T stock position financed with 50% upfront capital. That is a large difference. It is also exactly why losses can arrive quickly if the stock moves against you.
Shorting is another practical reason these contracts could find users. In the stock market, a short sale means locating shares, borrowing them, paying whatever borrow cost applies and living with recall risk. In a futures contract, you sell the future. No stock loan desk is needed. For a liquid name such as Nvidia, the current borrow fee is not the scary part: ChartExchange showed an Interactive Brokers borrow fee of 0.28% on July 23, with shares available. The advantage is operational simplicity, not magic.
OneChicago is the warning label
US traders have seen this movie before. OneChicago launched in 2002, backed by CME, the Chicago Board of Trade and CBOE, then spent years struggling for volume before it stopped trading on September 21, 2020. The product never became the mainstream stock hedge its backers wanted.
The regulatory setup did not help. Security futures sit between the SEC and the CFTC, and the old framework kept margin less attractive than the futures crowd wanted. In a 2020 final rule, the CFTC and SEC noted that OneChicago had stopped operations and lowered the required margin level for unhedged security futures from 20% to 15%. That change is part of the reason CME's relaunch looks more credible than the old version.
Still, liquidity will decide this. RCM Alternatives argued in a July 21 analysis that the first attempt failed because options already owned the market, liquidity never arrived, and the whole regulatory setup was a mess. That is blunt, and it is right. A clever contract with wide spreads is not a useful contract. Market makers have to show up, and traders have to keep coming back after the first week of curiosity fades.
SpaceX is the odd name in the list, and not because CME invented a private-company workaround. CME's product page lists SPCX among the underlying stocks, and recent market coverage has treated SpaceX as a publicly traded stock after its June 2026 IPO. That means the original caution about a private reference-price settlement does not hold. The real question is whether a newly listed, high-profile stock with heavy retail attention can support a liquid futures market from day one.
Frankly, this launch is not about whether futures are cleaner than options on paper. They are. It is about whether CME can make single-name futures feel ordinary to traders who already have stock, options, swaps, ETFs and leveraged funds competing for the same exposure. The mechanics now look better than OneChicago's. The history is still sitting there, useful and uncomfortable.
Also read: Alphabet's first negative free cash flow in 22 years signals the end of Big Tech's AI spending blank check • Shein swung from a $395 million profit to a $99 million loss and is still trying to go public at $50 billion • AI companies have signed enough nuclear deals to power 7 million homes and uranium stocks are surging
